Sandra P. D’Angelo

Also affiliated with Cornell University, Kettering University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.618Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009472

Top 32%

0.618DataRank

Top 32%16 citations

James L. Chen, Austin C Goodrich, Brian A. Van Tine, Jordan D. Campbell, Allison L. Richards +9 more

Papers

Driven by 28 papers — median percentile 68. Top paper: “Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab”.

Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab

JAMA Oncology(2020)10.1001/jamaoncol.2019.6152

N/A

5.0DataRank · unranked

207 citations

Cristina R. Antonescu, Timothy G. Bowler, Rodrigo Ramella Munhoz, Ping Chi, Mark A. Dickson +21 more

Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3909

N/A

0.627DataRank · unranked

16 citations

Li‐Xuan Qin, Niedzica Camacho, Ciara M. Kelly, Sandra P. D’Angelo, Mark A. Dickson +19 more

A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009472

Top 32%

0.618DataRank

Top 32%16 citations

James L. Chen, Austin C Goodrich, Brian A. Van Tine, Jordan D. Campbell, Allison L. Richards +9 more

HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0832

N/A

0.494DataRank · unranked

26 citations

Kenneth Seier, Chaitanya Bandlamudi, Mark A. Dickson, Mrinal M. Gounder, Mary Lou Keohan +12 more

The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation‐associated angiosarcomas of the breast

Histopathology(2021)10.1111/his.14433

N/A

0.489DataRank · unranked

25 citations

Bin Xu, Sandra P. D’Angelo, Evan Rosenbaum, George Plitas, Dara S. Ross +3 more

Case Report: Response to Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 Cases

Frontiers in Oncology(2021)10.3389/fonc.2021.725484

N/A

0.484DataRank · unranked

9 citations

Sandra P. D’Angelo, Ciara M. Kelly, Robert H. Siegelbaum, Charles Fisher, Cristina R. Antonescu +2 more

Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response

Modern Pathology(2023)10.1016/j.modpat.2023.100165

N/A

0DataRank · unranked

40 citations

Walid K. Chatila, Cecilia Lezcano, Christopher A. Febres‐Aldana, Nikolaus Schultz, Chad Vanderbilt +10 more

Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2378

N/A

0DataRank · unranked

36 citations

Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu, Rodrigo Gularte‐Mérida, Marimar Benitez +31 more

Stereotactic body radiation therapy for sarcoma pulmonary metastases

Radiotherapy and Oncology(2023)10.1016/j.radonc.2023.109824

N/A

0DataRank · unranked

16 citations

Stephanie Lobaugh, Zhigang Zhang, Mark A. Dickson, Evan Rosenbaum, Sandra P. D’Angelo +12 more

Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0140

N/A

0DataRank · unranked

11 citations

Kenneth Seier, Martina Bradić, Ciara M. Kelly, Sujana Movva, Benjamin A. Nacev +12 more

A multicenter phase II study of cabozantinib + nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11503

N/A

0DataRank · unranked

35 citations

Jacob B. Allred, Scott M. Schuetze, Elizabeth J. Davis, Michael J. Wagner, Andrew Poklepovic +10 more

A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps11590

N/A

0DataRank · unranked

3 citations

Evan Rosenbaum, Rodrigo Gularte Mérida, Mark A. Dickson, Mary Louise Keohan, Mrinal M. Gounder +15 more

Data from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

(2023)10.1158/2767-9764.c.6886242.v1

N/A

0DataRank · unranked

0 citations

Kenneth Seier, Martina Bradić, Ciara M. Kelly, Sujana Movva, Benjamin A. Nacev +12 more

Data from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

(2023)10.1158/2767-9764.c.6886242

N/A

0DataRank · unranked

0 citations

Kenneth Seier, Martina Bradić, Ciara M. Kelly, Sujana Movva, Benjamin A. Nacev +12 more

Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy

Nature Cancer(2024)10.1038/s43018-024-00743-y

N/A

0DataRank · unranked

59 citations

Neda Nemat‐Gorgani, Timothy John Ellis-Caleo, David G.P. van IJzendoorn, Timothy J. Sears, Anish Somani +20 more

Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2519

N/A

0DataRank · unranked

20 citations

Kenneth Seier, Viswatej Avutu, Lauren B. Banks, Jason E. Chan, Ping Chi +20 more

A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110478

N/A

0DataRank · unranked

7 citations

Sandra P. D’Angelo, Gloria Wasilewski, Alexa Steckler, Ming Lian, Zhigang Zhang +4 more

Clinicopathologic and molecular correlates to neoadjuvant chemotherapy‐induced pathologic response in breast angiosarcoma

Genes Chromosomes and Cancer(2024)10.1002/gcc.23240

N/A

0DataRank · unranked

6 citations

Josephine K. Dermawan, M. Gabriela Kuba, Aimeé M. Crago, Samuel Singer, William D. Tap +5 more

Data from Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

(2024)10.1158/1078-0432.c.7077823.v1

N/A

0DataRank · unranked

0 citations

Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu, Rodrigo Gularte‐Mérida, Marimar Benitez +31 more

1762P Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1853

N/A

0DataRank · unranked

0 citations

Martina Bradić, Sara Saunds, V. Avutu, Jason W. Chan, Sandra P. D’Angelo +15 more

Infections in Patients with Solid Tumors Undergoing Adoptive Cellular Therapy

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.02.017

N/A

0DataRank · unranked

2 citations

Jumanah N Algazaq, Kenneth Seier, Rhoena Desir-Camille, Li-Xuan Qin, Olayode Babatunde +12 more

High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012357

N/A

0DataRank · unranked

1 citations

Martina Bradić, Hyung Jun Woo, Allison L. Richards, Ciara M. Kelly, Mark A. Dickson +17 more

Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade

npj Precision Oncology(2025)10.1038/s41698-025-00878-w

N/A

0DataRank · unranked

2 citations

Sara Coca Membribes, Cristina Anthonescu, Martina Bradić, Bernard O’Malley, Irina Linkov +9 more

A multicenter phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401): Results of expansion cohorts.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11511

N/A

0DataRank · unranked

50 citations

Michelle R. Mahoney, Suzanne George, Cristina R. Antonescu, David A. Liebner, Brian Andrew Van Tine +6 more

18F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma

Journal of Nuclear Medicine(2021)10.2967/jnumed.121.262882

N/A

0DataRank · unranked

5 citations

Christopher A. Barker, Audrey Mauguen, Sandra P. D’Angelo, Randy Yeh, Neeta Pandit‐Taskar +1 more

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

Nature Communications(2022)10.1038/s41467-022-30453-x

N/A

0DataRank · unranked

215 citations

Francisco Sánchez-Vega, Shaleigh Smith, Cristina R. Antonescu, Evan Rosenbaum, Hongyu Shi +42 more

Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004149

N/A

0DataRank · unranked

58 citations

Cristina R. Antonescu, Shaleigh Smith, Martina Bradić, Daniel Kashani, Allison L. Richards +17 more

A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3911

N/A

0DataRank · unranked

69 citations

Li‐Xuan Qin, Karissa Whiting, Allison L. Richards, Viswatej Avutu, Jason E. Chan +18 more

Sandra P. D’Angelo

Indexed papers

Top data-sharing exemplar

Papers